VEXMX vs. AGIO

In the year-to-date period, VEXMX achieves a -3.15% return, which is significantly lower than AGIO's -2.34% return. Over the past 10 years, VEXMX has outperformed AGIO with an annualized return of 8.35%, while AGIO has yielded a comparatively lower -12.62% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Vanguard Extended Market Index Fund (VEXMX) and Agios Pharmaceuticals, Inc. (AGIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current VEXMX Sharpe Ratio is 0.40, which is higher than the AGIO Sharpe Ratio of -0.26. The chart below compares the historical Sharpe Ratios of VEXMX and AGIO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

VEXMX's dividend yield for the trailing twelve months is around 1.08%, while AGIO has not paid dividends to shareholders.

The maximum VEXMX drawdown since its inception was -58.17%, smaller than the maximum AGIO drawdown of -87.36%. Use the drawdown chart below to compare losses from any high point for VEXMX and AGIO.

The current volatility for Vanguard Extended Market Index Fund (VEXMX) is 6.18%, while Agios Pharmaceuticals, Inc. (AGIO) has a volatility of 12.50%. This indicates that VEXMX experiences smaller price fluctuations and is considered to be less risky than AGIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.